SeqOnce Biosciences
Timothy Harkins is a seasoned executive in the genomics industry, currently serving as the Chief Operating Officer at SeqOnce Biosciences Inc. since 2022, focused on advancing NGS and RT-PCR applications. Harkins held various pivotal roles, including Product Manager at NVIDIA after its acquisition of Parabricks, where efforts centered on integrating AI into genomics, and as President and CEO at Swift Biosciences, where a substantial turnaround was achieved. Additional experience includes director positions at Life Technologies and Roche, where successful commercial activities were directed in the NGS market. Harkins' career began at Applied Biosystems as a Senior Scientist, progressing through roles in product management and strategic development. Educational qualifications include a Ph.D. in Chemistry from the University of Utah and a BA from Kenyon College, alongside post-doctoral research in enzymatic mechanisms.
This person is not in any teams
This person is not in any offices
SeqOnce Biosciences
SeqOnce Biosciences is a privately held company located in Pasadena, California. Its core competencies, which include enzymology, nucleic acid chemistry, sample processing, and manufacturing, have served as engines for innovation, development of intellectual property, and ongoing product development.